Regulations & standards
21 CFR 201.125 — Drugs for use in teaching, law enforcement, research, and analysis
The U.S. federal regulation describing when a drug may be exempt from adequate-directions-for-use labeling because it is shipped for research or analysis.
The current text is published in the Electronic Code of Federal Regulations. The exemption it describes has specific conditions; whether those conditions are met for any particular product, shipment and recipient is a question for qualified regulatory counsel and is recorded per product in our compliance registry.